<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03847792</url>
  </required_header>
  <id_info>
    <org_study_id>MS/18.09.306</org_study_id>
    <nct_id>NCT03847792</nct_id>
  </id_info>
  <brief_title>Analgesic Effect Of Intra-articular Bupivacaine Fentanyl for Postoperative Pain Relief in Knee Arthroscopic Surgery</brief_title>
  <official_title>Analgesic Effect Of Intra-articular Dexamethasone Versus Fentanyl Added as an Adjuvant to Bupivacaine for Postoperative Pain Relief in Knee Arthroscopic Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      However, local anesthetic agents can produce analgesia for a limited time when used as a
      single injection. Bupivacaine is a local anesthetic that has an immediate action on pain by
      blocking peripheral afferents. However, as the ideal analgesic, the drug must cover the whole
      postoperative period (â‰¥ 24 hours); therefore, bupivacaine is usually combined with many
      adjutants to provide long-lasting post-arthroscopy analgesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intr-articular drug administration has gained popularity because of its simplicity and
      efficacy in achieving anesthesia for diagnostic and operative arthroscopy and for providing
      postoperative analgesia .although the knee joint has been examined most commonly, arthroscopy
      of other joints such as shoulder, ankle, wrist, metatarsophalangeal and temporomandibular
      joints is being increasingly used.

      Intra-articular installation of local anesthesia during arthroscopic procedures has been used
      by many orthopedic surgeons to provide pain relief after surgery.The aim of this study was to
      evaluate the analgesic efficacy of intra-articular dexamethasone versus fentanyl added as an
      adjuvant to bupivacaine in patients undergoing knee arthroscopic surgery
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 31, 2019</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of postoperative analgesia</measure>
    <time_frame>for 24 hour after surgery</time_frame>
    <description>Time to the first request of pethidine in minutes within the first 24 hours postoperatively</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total analgesic requirement</measure>
    <time_frame>for 24 hour after surgery</time_frame>
    <description>Total analgesic requirement of pethidine will be recorded during the first 24 hours following surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean arterial blood pressure</measure>
    <time_frame>At 1,2,4,6,8,12,18 and 24 hours postoperatively.</time_frame>
    <description>Mean arterial blood pressure measured in mm Hg and assessed at 1,2,4,6,8,12,18 and 24 hours following the discharge of the patient from the operating theatre.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>At 1,2,4,6,8,12,18 and 24 hours postoperatively.</time_frame>
    <description>Heart rate will be measured in beats/minute and assessed at 1,2,4,6,8,12,18 and 24 hours following the discharge of the patient from the operating theatre.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain score</measure>
    <time_frame>measured at 1,2,4,6,8,12,18 and 24 hours postoperatively.</time_frame>
    <description>Measured with visual analogue score(VAS):0=no pain and 100=worst imaginable pain measured at 1,2,4,6,8,12,18 and 24 hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patients' satisfaction</measure>
    <time_frame>for 24 hour after surgery</time_frame>
    <description>satisfaction score from 1 to 4; as 4=Excellent ,3=good ,2=satisfactory and 1=poor will be measured after 24 hours.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">87</enrollment>
  <condition>Knee Arthroscopic Surgery</condition>
  <arm_group>
    <arm_group_label>Group DB/Dexamethasone-Bupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive an intra-articular injection of 8mg dexamethasone added to18mL of 0.25% bupivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group FB /Fentanyl-Bupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive an intra-articular injection of 1 ug/kg fentanyl added to 18 mL of 0.25% bupivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group PB/Placebo-Bupivacaine</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will receive an intra-articular injection of 2 mL isotonic saline added to 18 mL of 0.25% bupivacaine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Group DB/Dexamethasone-Bupivacaine</intervention_name>
    <description>The patient will receive an intra-articular injection of 18ml bupivacaine 0.25% added to 8mg dexamethasone.</description>
    <arm_group_label>Group DB/Dexamethasone-Bupivacaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Group FB /Fentanyl-Bupivacaine</intervention_name>
    <description>The patient will receive an intra-articular injection of 1 ug/kg fentanyl added to 18ml of 0.25% bupivacaine.</description>
    <arm_group_label>Group FB /Fentanyl-Bupivacaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Group PB/Placebo-Bupivacaine</intervention_name>
    <description>Patients will receive an intra-articular injection of 2ml isotonic saline added to 18ml of 0.25% bupivacaine.</description>
    <arm_group_label>Group PB/Placebo-Bupivacaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologists physical status (ASA) I or II

        Exclusion Criteria:

          -  Contraindication to spinal anesthesia.

          -  Allergy to the study drugs.

          -  Refusal of the patients.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohamed M Sultan, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Professor of Anaesthesia and Surgical Intensive Care</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hazem ESM Weheba, MD</last_name>
    <role>Study Director</role>
    <affiliation>Assistant Professor of Anaesthesia and Surgical Intensive Care</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hosam Ibrahim EL said saber, MD</last_name>
    <role>Study Director</role>
    <affiliation>Lecturer of Anaesthesia and Surgical Intensive Care</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mohamed A Sultan, MD</last_name>
    <phone>00201062839014</phone>
    <phone_ext>00201121516041</phone_ext>
    <email>dr_sultan_icu@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hazem ESM Weheba, MD</last_name>
    <phone>00201121516041</phone>
    <phone_ext>00201121516041</phone_ext>
    <email>hazemmoawad@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mohamed A Sultan</name>
      <address>
        <city>Mansourah</city>
        <state>DK</state>
        <zip>050</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mansoura University</name>
      <address>
        <city>Mansourah</city>
        <state>Eastern</state>
        <zip>050</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohamed, A Sultan, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>February 19, 2019</study_first_submitted>
  <study_first_submitted_qc>February 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 20, 2019</study_first_posted>
  <last_update_submitted>June 19, 2019</last_update_submitted>
  <last_update_submitted_qc>June 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Following publication</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>forever</ipd_time_frame>
    <ipd_access_criteria>tawfik20192@gmail.com</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

